Evidence map›Paper›PMID 31773922›Full record

ArticleCancer medicine2020

Use of artificial nutrition near the end of life: Results from a French national population-based study of hospitalized cancer patients.

Karine Baumstarck, Laurent Boyer, Vanessa Pauly, Veronica Orleans, Anthony Marin, Guillaume Fond, Lucas Morin, Pascal Auquier, Sébastien Salas

Abstract read
In one paragraph

Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. The use of artificial nutrition at the end-of-life: a cross-sectional survey exploring the beliefs and decision-making among physicians and nurses.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Karine BaumstarckCEReSS-Health Service Research and Quality of Life Center, Aix-Marseille Univ., Marseille, France.ORCID 0000-0003-3602-6766
Laurent BoyerCEReSS-Health Service Research and Quality of Life Center, Aix-Marseille Univ., Marseille, France.ORCID 0000-0003-1229-6622
Vanessa PaulyCEReSS-Health Service Research and Quality of Life Center, Aix-Marseille Univ., Marseille, France.
Veronica OrleansDepartment of Medical Information, APHM, Marseille, France.
Anthony MarinDepartment of Adult Oncology, APHM, Marseille, France.
Guillaume FondCEReSS-Health Service Research and Quality of Life Center, Aix-Marseille Univ., Marseille, France.
Lucas MorinDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Pascal AuquierCEReSS-Health Service Research and Quality of Life Center, Aix-Marseille Univ., Marseille, France.
Sébastien SalasDepartment of Adult Oncology, APHM, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of artificial nutrition, defined as a medical treatment that allows a non-oral mechanical feeding, for cancer patients with limited life expectancy is deemed nonbeneficial. High-quality evidence about the use of artificial nutrition near the end of life is lacking. This study aimed (a) to quantify the use of artificial nutrition near the end-of-life, and (b) to identify the factors associated with the use of artificial nutrition.

methodsThis was a retrospective cohort study of decedents based on data from the French national hospital database. The study population included adult cancer patients who died in hospitals in France between 2013 and 2016 and defined to be in a palliative condition. Use of artificial nutrition during the last 7 days before death was the primary endpoint.

resultsA total of 398 822 patients were included. The median duration of the last hospital stay was 10 (interquartile range, 4-21) days. The artificial nutrition was used for 11 723 (2.9%) during the last 7 days before death. Being a man, younger, having digestive cancers, metastasis, comorbidities, malnutrition, absence of dementia, and palliative care use were the main factors associated to the use of artificial nutrition.

conclusionThis study indicates that the use of artificial nutrition near the end of life is in keeping with current clinical guidelines. The identification of factors associated with the use of artificial nutrition, such as cancer localization, presence of comorbidities or specific symptoms, may help to better manage its use.

Indexed as

Nutritional SupportPalliative CareQuality of LifeTerminal CareAgedAged, 80 and overFemaleFollow-Up StudiesHospitalizationHumansLife ExpectancyMaleMiddle AgedNeoplasmsPrognosisRetrospective Studiesartificial nutritioncancerend-of-lifehealth services researchregistry database

Identifiers

PMID31773922
PMCPMC6970047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.